Navigation Links
NYU study points to lasting impact of mild hearing loss on neurological processes
Date:8/30/2007

Mild to moderate forms of hearing loss can have a lasting impact on the auditory cortex, according to findings by researchers at New York Universitys Center for Neural Science. The study, which is the first to show central effects of mild hearing loss, appears in the latest issue of the Journal of Neuroscience.

The study was authored by NYU scientists Han Xu, Vibhakar Kotak, and Dan Sanes, working in NYUs Center for Neural Science.

Previously, researchers had been unable to conclusively determine the neurological impact of mild forms of hearing loss, which occurs when the pathway by which sound reaches the cochlea is disruptedsuch as is experienced with middle ear infections during childhood. The NYU study sought to address this question in an animal model by measuring the impact of conductive hearing loss without injury to the cochlea.

The researchers induced hearing loss in the subjects during early development, then measured the functionality of neural connections within the subjects auditory cortex, which processes all acoustic cues.

The results showed that the projection to auditory cortex had changed following a brief period of hearing loss. Specifically, the researchers found that the synaptic response of the auditory neurons adapted more rapidly and to a greater extent. They also found that auditory cortex neurons became more sensitive to stimulation.

These findings indicate that auditory cortex function is susceptible to relatively modest loss of hearing loss during development and suggest that perceptual deficits may be linked to alterations in the central nervous system.


'/>"/>
Contact: James Devitt
james.devitt@nyu.edu
212-998-6808
New York University
Source:Eurekalert

Page: 1

Related medicine news :

1. Gene study links endometriosis, infertility
2. Study reveals how stress can make you sick
3. Study points out that HIV vaccine may not be accepted easily
4. A new study surpasses Gene Therapy Hurdle
5. Tomato Sauce reduces Cancer Risk- Study
6. A question on study of Adult Stem Cell
7. Study on obesity and heart failure
8. National Lung Study in the process
9. Marijuana gateway theory strengthened by study of twins
10. Old theory of adaptation confirmed by new study
11. Study casts doubt on keyboard ills
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... NY (PRWEB) , ... April 28, 2017 , ... ... celebrating its 5th anniversary. SearchLight is the premier online modeling resource for fluorescence ... more than 30,000 active users during last 5 years spanning the globe, SearchLight ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying to meet talent ... an outdated healthcare executive resume. , “If you’re a healthcare executive open to new ... wondering if it’s as ready as you are for a new job search. I’ve ...
(Date:4/27/2017)... ... April 27, 2017 , ... SyncDog, ... sponsorship at MobileIron Live! 2017 in Santa Clara, California. Each year, ... educational approach to helping organizations maximize the benefits of mobility in their operations ...
(Date:4/27/2017)... ... April 27, 2017 , ... Plastic Surgery Associates is ... been asked to present at the upcoming Aesthetic Meeting. Held in San Diego, at ... Drs. Furnas and Canales will lend their expertise to the Premier Global Hot Topics ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... the ATA 2017 President’s Awards recipients, comprised of organizations and individuals who ... , The ATA 2017 President’s Awards recognize individuals and organizations on ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 The Mobile X-Ray product segment ... healthy CAGR during the forecast period Mobile X-Ray ... global digital mobile X-Ray devices market, which is estimated to ... expanding at a CAGR of 7% over the forecast period. ... of more than US$ 100 Mn in 2017 over 2016. ...
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
Breaking Medicine Technology: